# MIrabegron With oveRACtive bLadder Symptoms in mEn

> **NCT02361502** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 462 (estimated)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** mirabegron
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02361502
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 462 (ESTIMATED)
- **Last updated:** 2015-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361502, "MIrabegron With oveRACtive bLadder Symptoms in mEn". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02361502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*